Published in AIDS Weekly, July 22nd, 1996
The AVEG trials are sponsored by the U.S. National Institute of Allergy and Infectious Disease (NIAID) at six university-based clinical testing sites and two central immunological laboratories. According to the NIAID, AVEG investigators have evaluated 16 experimental vaccine antigens, ten adjuvants to enhance the immune responses stimulated by the vaccines, and a variety of different delivery vehicles, immunization routes and schedules.
Preliminary results of the AVEG...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.